The American Gastroenterological Association acknowledges the need for gastroenterologists to participate in and provide value-based care for both cognitive and procedural conditions. Episodes of care are designed to engage specialists in the movement toward fee for value, while facilitating improved outcomes and patient experience and a reduction in unnecessary services and overall costs. The episode of care model puts the patient at the center of all activity related to their particular diagnosis, procedure, or health care event, rather than on a physician's specific services. It encourages and incents communication, collaboration, and coordination across the full continuum of care and creates accountability for the patient's entire experience and outcome. This paper outlines a collaborative approach involving multiple stakeholders for gastrointestinal practices to assess their ability to participate in and implement an episode of care for obesity and understand the essentials of coding and billing for these services.
D
uring the past several decades, there has been a heightened awareness of the epidemic of obesity. The cost of this disease to our nation's health and health care economics has risen steadily despite the growing focus on its impact. The United States Preventive Service Task Force (USPSTF) recommends that all adults be screened for obesity, and those with a body mass index (BMI) of 30 kg/m 2 or higher be offered a referral to intensive multicomponent behavioral interventions. 1 The USPSTF recommends that clinicians screen children aged 6 years and older for obesity and offer referrals to comprehensive, intensive behavioral interventions to promote improvement in weight status. 2 The American Gastroenterological Association 3 (AGA) and other specialty societies have released guidelines on the assessment and management of patients with obesity. [4] [5] [6] [7] [8] [9] However, few specialty societies have focused on the business operational issues related to the management of patients with obesity at the practice level.
In 2015-2016, the AGA convened a series of workgroups to address the coordinated management of patients with obesity. This was in recognition of the significant role that obesity plays in the development of gastrointestinal disorders, gastroenterology fellowship training in nutritional disorders, and that gastroenterologists are uniquely trained to treat obesity as endoscopists who specialize in digestive and nutritional diseases. The Practice Guide on Obesity and Weight Management, Education and Resources (POWER) program was developed by the AGA to guide gastroenterologists in how to play a pivotal role in the multidisciplinary care of patients with obesity. 3 The AGA established the Obesity Episode of Care and Bundle Initiative Work Group to develop an episode framework to support value-based management of patients with obesity, focusing on the provision of nonsurgical and endoscopic services. This paper presents the recommendations of the workgroup.
Obesity is a chronic disease that requires individualized treatment approaches that may vary in scope and intensity throughout a patient's lifetime. As is true for the treatment of other chronic diseases, successful obesity care requires initial patient assessment, weight loss interventions, maintenance therapy, and often secondlevel therapies or intensification to address inadequate weight loss or weight regain. The cornerstone of therapy is a behavioral program that incorporates an individualized reduced calorie diet and increased physical activity. Second-level therapies can be initiated at the same time or sequentially. Providing patients with the cornerstones of therapy as described above is critical to both their safety and their success with managing their obesity and must be an essential part of any bariatric endoscopic practice.
The goal of this initiative is to provide gastroenterologists with strategies to obtain compensation for high value care in a flexible format that can be adapted to the resources of both large and small practices. The services identified in this paper may be provided to patients with obesity by physicians or other qualified health care professionals within the confines of the practice, contracted with the practice, or obtained externally. However, it is essential that data coordination takes place between all members of the multidisciplinary team who are providing therapeutic services to the patient to ensure high value continuity of care.
In this paper, the following terms are used when referring to health care professionals. A "physician or other qualified health care professional" is an individual who is qualified by education, training, licensure/ regulation, and facility privileging who performs a professional service within his/her scope of practice and independently reports that professional service. These professionals are distinct from "clinical staff." A clinical staff member is a person who works under the supervision of a physician or other qualified health care professional and who is allowed by law, regulation, and facility policy to perform or assist in the performance of a specified professional service, but who does not individually report that professional service. 10 The Basic Concepts of an Episode-of-Care Framework An episode of care covers all services provided to a patient during treatment for a clinical condition or procedure. An episode-of-care framework should address a construct that does the following:
Covers a predefined set of services across the entire continuum of care, encompassing multiple providers and settings, for the management of a condition or procedure for a predetermined period, with a relatively measurable and clearly defined start and end point.
Could be used as a "unit of accounting" to set a single payment (budget) for the management of the episode of care, for example, for 1 year of care for an obese patient.
Could also be used as a "unit of accountability" for providers that take on the clinical responsibility for managing the episode of care.
Could be used to drive incentives for efficient and effective care through shared savings arrangements, with predefined quality and cost end points.
Thus, the episode-of-care framework aims to improve the value of health care by encouraging providers to do the following:
Provide services that are appropriate.
Improve collaboration among various health care professionals and providers.
Control costs through the following:
B Avoiding unnecessary services.
B Using cost-efficient sites of service.
B Reducing potentially avoidable complications.
Improve patient outcomes that can be measured by predefined quality metrics. 
Patient Obesity Assessment
Patient assessment. Patients with obesity will present to the practice in 1 of 2 ways, either existing patients known to the practice or new patients referred to the practice, leading to an evaluation and management (E/M) service. Depending on payer policy, licensure, or state regulation, a physician or other qualified health care professional may perform the patient examination, including assessment for readiness for weight loss, by using the appropriate E/M service (Table 1) .
Payers may require reasonable documentation to ensure that a service is consistent with the patient's insurance coverage and to validate the site of service, the medical necessity and appropriateness of the diagnostic and/or therapeutic services provided, and/or that services furnished were accurately reported.
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Obesity screening is one of several distinct preventive services mandated by national and state regulations. Many different types of health care professionals can offer screening for obesity. Screening for obesity is typically performed by calculating BMI. A complete discussion of obesity screening as part of behavioral therapy is included in the Preventive Medicine and Intensive Behavioral Therapy portion of the Intense Weight Loss Intervention section below.
Administration of a standardized health risk assessment, depression assessment, and diagnostic services can be separately reported in addition to E/M services. The 2017 American Medical Association Current Procedural Terminology (CPT) manual states that "the actual performance and/or interpretation of diagnostic tests/ studies ordered during a patient encounter are not included in the levels of E/M services. Physician performance of diagnostic tests/studies for which specific CPT are available may be reported separately, in addition to the E/M code." 10 CPT code 99240 (Administration and interpretation of health risk assessment instrument) may be reported if the service meets the plan's medical necessity guidelines and is separately billable and reimbursed. CPT codes for preventive medicine E/M services (99383-99387) may be considered when billing for initial screening or periodic screening of the patient for obesity as a preventive service. A complete discussion of preventive medicine E/M services is included in the Preventive Services section below.
Medical Evaluation
The medical evaluation for a patient with obesity may include assessment for underlying etiologies, screening for causes of secondary weigh gain, and identification of obesity-related comorbidities.
Laboratory tests. Assessment of comprehensive metabolic panel (80053), lipid panel (80061), thyroid function tests (84439, 84443), fasting blood glucose (82947) or hemoglobin A1c (83036), and/or hepatic tests (AST-84450, ALT-84460, total bilirubin-82247, direct bilirubin-82248) may be considered if medically necessary.
Sleep apnea. Assessment of patients by using a sleep survey such as the Epworth Sleepiness Scale or STOP-BANG may be indicated to determine whether referral for assessment for and/or management of obstructive sleep apnea is necessary. 
Dietary Evaluation
Nutritional assessment is an important part of the treatment of many diseases and conditions. Initial assessment and intervention services delivered by a dietitian, including nutritional counseling and behavior change interventions, can be reported by using CPT code 97802 (Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes). Medicare Part B covers 
Psychological Evaluation
A full psychological and behavioral assessment should complement the initial medical evaluation of individuals entering a weight loss treatment plan. Centers for Medicare and Medicaid Services (CMS) and other third-party payers require a presurgical psychological evaluation as part of the approval process for covered bariatric surgery procedures. We recommend that patients being evaluated for obesity management undergo a psychological evaluation, regardless of whether the patient will be participating in a lifestyle management program or have additional pharmacologic and/or bariatric endoscopic interventions. Psychological assessment and treatment are also often deemed medically necessary and can be ordered by any treating physician. A psychological and behavioral assessment can be conducted by a psychologist or other qualified mental health provider who specializes in obesity.
The purpose of the psychological evaluation is to (1) better understand the biological, psychological, social, and behavioral factors that may be contributing to weight gain (eg, binge eating disorder, night eating syndrome, excessive stress), (2) determine whether there are any psychosocial consequences of obesity (eg, depression, social withdrawal, body image disturbance), (3) assess the patient's expectations and beliefs about weight and weight loss, and (4) identify any contraindications to a specific weight loss treatment or procedure (eg, substance use disorder, self-induced purging). Information from the assessment is used to help treatment planning and ensure patients are being set up to succeed. Results of the assessment including clearance for weight loss procedures and other treatment recommendations should be included in the patient's medical record. Practices that do not have an integrated psychologist or other mental health care provider can fulfill this aspect of care by referring to an outside provider, incorporating the assessment and recommendations for treatment into the patient's electronic health record.
Health and behavior assessment codes 96150 and 96151 are used to determine the biopsychosocial factors affecting a patient's primary medical condition and any treatment problems. Health and behavior intervention codes 96152-96155 are used when services are rendered to a patient, a group of patients, or a patient's family to improve a patient's health and wellbeing by using cognitive, behavioral, social, and/or psychological interventions that have been shown to improve specific disease-related problems. These codes are for licensed non-physician behavioral health providers to report a brief, time-limited behavioral health consultation with patients seen in medical settings. Health and Behavior Assessment/Intervention services are intended to help patients and their treating physicians better manage primary medical conditions such as diabetes, obesity, heart disease, and cancer.
Health and Behavior Assessment (96150-96151) and Intervention (96152-96155) codes are billed in 15-minute units, and multiple units can be billed for 1 visit ( Table 2) .
Codes 96150-96155 should not be used to describe services provided to patients who have a primary mental health or psychiatric diagnosis.
Health and Behavior Assessment/Intervention codes should not be used to describe services provided to patients who have a primary mental health or psychiatric diagnosis. Services provided to patients who have a primary mental health or psychiatric diagnosis should be coded and reported in accordance with the psychiatry services section of the CPT manual (Table 3) .
For some patients, psychological testing may be necessary to establish a treatment plan. Psychological testing is a comprehensive battery of tests and clinical interview to assess self-concept, cognitive skills, or personality traits. Psychological testing is the responsibility of physicians and psychologists appropriately trained to perform and interpret test results, when this type of testing evaluation falls within their scope of professional practice. Screening can also be performed by other qualified health care professionals and/or through the use of a computer. There should be a reasonable expectation that the individual's illness, condition, or level of functioning will be stabilized, improved, or maintained through treatment known to be effective for the patient's illness or other types of conditions where assessment contributes to the care of the patient. Psychological testing in a patient with obesity may be medically necessary when:
Testing is for the purpose of helping to establish the diagnosis of and to develop a treatment plan for a mental disorder, when this information is not adequately available from one or more comprehensive medical or behavioral health evaluations with the member and appropriate ancillary sources (for example, family members, health care providers, school records); AND Standardized testing is based on published national normative data; AND There is evidence to suggest that the testing results will have a timely and direct impact on the patient's treatment plan.
Psychological testing services can be administered by the psychologist, physician, technician, or computer, with interpretation by a psychologist, physician, or qualified health care professional, depending on how the testing was administered (Table 4) .
Medicare beneficiaries are eligible for annual screening for depression in a primary care setting that has staff-assisted depression care supports in place to assure accurate diagnosis, effective treatment, and follow-up. At a minimum level, staff-assisted depression care supports consist of clinical staff (eg, nurse) and/or qualified health care professionals in the practice who can advise the physician of screening results and can coordinate referrals for mental health treatment. More comprehensive care supports include a case manager working with the primary physician, planned collaborative care between the primary care provider and mental health clinicians, and patient education and support for patient self-management.
Healthcare Common Procedure Coding System (HCPCS) G0444 (Annual depression screening, 15 minutes) can be reported once per 12 months for Medicare patients, when services are provided with the following place of service codes: Medicare coverage is limited to screening services and does not include treatment options for depression or any diseases, complications, or chronic conditions resulting from depression, and it does not address therapeutic interventions such as pharmacotherapy, combination therapy (counseling and medications), or other interventions for depression. Medicare does not specify the type of tool or instrument used for screening for depression. 
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Intense Weight Loss Intervention
Developing a personalized program of diet/ nutritional counseling and behavior change including psychosocial issues and physical activity is the cornerstone or first-line therapy to achieve weight loss for the patient.
Diet: nutritional counseling and obesity management. Nutritional counseling/MNT is an important part of the prevention and treatment of many diseases and conditions. It consists of a nutritional assessment, the assignment of a specific diet, counseling services, and/or specialized therapies to treat an illness or condition. Payer coverage policies should be reviewed to assess whether provision of dietitian services is limited to certain conditions. CPT codes exist for the provision of services delivered by a dietitian, including nutritional counseling and behavior change interventions (Table 5) .
Several level II HCPCS "S" codes exist to describe nutrition services provided on an individual or group (classroom) service. Medicare does not recognize "S" codes; however, these codes may be useful for claims to private payers. Check with the payer to see whether the services in Table 6 are covered under the patient's plan document.
At present, Medicare limits coverage of dietitians providing MNT services to those Medicare beneficiaries who have a diagnosis of diabetes, renal disease, or renal transplant in the past 3 years. If additional hours of medical nutrition services are performed beyond the number of hours typically covered (3 hours in the initial calendar year, and 2 follow-up hours in subsequent years with a physician referral), when the treating physician determines there is a change of diagnosis or medical condition that makes a change in diet necessary, dietitian services for reassessment and subsequent interventions (in a Medicare beneficiary who has a diagnosis of diabetes, renal disease, or kidney transplant in the past 3 years) may be billed by using HCPCS codes G0270 or G0271 (Table 7) .
Registered dietitians may not bill directly for G0447 but may provide this service if billed "incident to a physician service."
Recommendations from the Academy of Nutrition and Dietetics on frequency of MNT services for patients with obesity are addressed in the Position of the Academy of Nutrition and Dietetics: Interventions for the treatment of overweight and obesity in adults. 13 Behavior change. Counseling to address behavior and lifestyle is a critical component to successful obesity management. Although these services are typically reimbursable by Medicare and commercial payers, it is important to be aware of rules for billing and frequency of reporting allowed.
Obesity Preventive Services
Effective for plan years on or after September 23, 2010, the Patient Protection and Affordable Care Act (PPACA), public law (PL) 111-148, 14 as amended by the Health Care and Education Reconciliation Act of 2010, PL 111-152, 15 with the exception of groups maintaining "grandfathered" status, requires plans to provide 100% coverage for preventive care services. It is unclear whether this requirement will continue in calendar year 2017 and beyond. Grandfathered groups are not subject to this requirement, but many of these groups have opted to cover preventive services with no cost sharing.
This means that members have no cost-sharing responsibility when preventive services are rendered by an in-network provider (ie, covered at 100% of eligible expenses without deductible, coinsurance, or copayment). Members may still be required to pay a copayment, deductible, or coinsurance for preventive services received from out-of-network providers or for nonpreventive services received in conjunction with a preventive services visit. In June 2010, the USPSTF recommended that clinicians screen children aged 6 years and older for obesity and offer or refer them to comprehensive, intensive behavioral intervention to promote improvement in weight status. In June 2012, the USPSTF recommended screening all adults for obesity, citing adequate evidence that intensive, multicomponent behavioral interventions for obese adults can lead to an average weight loss of 4-7 kg (8.8-15.4 pounds). These interventions also improve glucose tolerance and other physiological risk factors for cardiovascular disease. Clinicians should therefore offer or refer patients with a BMI of 30 kg/m 2 or greater to intensive multicomponent behavioral interventions. 16 CPT codes for Preventive Services could be considered when billing for initial or periodic screening of the patient for obesity as a preventive service (Table 8) . It is not necessary to append modifier 33 (Preventive Service) to the preventive medicine CPT codes in Table 8 .
Documentation of preventive visits should include:
A comprehensive history and physical exam;
A description of the status of chronic, stable problems that are not "significant enough to require additional work";
Notes concerning the management of minor problems that do not require additional work;
Notes concerning age-appropriate counseling, screening labs, and tests; and Orders for vaccines based on age and risk factors (if appropriate). 17 CPT notes that the comprehensive history that must be obtained as part of a preventive visit has no chief complaint or present illness as its focus. Rather, it requires a "comprehensive system review and comprehensive or interval past, family, and social history, as well as a comprehensive assessment/history of pertinent risk factors." The preventive comprehensive exam differs from a problem-oriented comprehensive exam because its components are based on age and risk factors rather than a presenting problem. The service can be performed by both physicians and mid-level providers.
When providing a preventive visit with a problemoriented E/M service or procedural service on the same day, coding the second service with modifier 25 (Significant, separately identifiable E/M service by the same physician on the same day of the procedure or other service) may enable payment for both services. CPT states that modifier 25 is appropriate when there is a "significant, separately identifiable evaluation and management service by the same physician on the same day." If the second service requires enough additional work that it could stand on its own as an office visit, use modifier 25. Modifier 25 should be attached to the problem-oriented E/M code or procedural service.
Preventive Medicine and Intensive Behavioral Therapy: Risk Factor Reduction and Counseling in Adults
Obesity screening and behavioral therapy are distinct preventive services that may be mandated by national and/or state regulations. Many different types of health care professionals can offer screening and behavioral therapy for obesity. Screening for obesity is typically performed by calculating BMI. Behavioral interventions generally consist of motivation enhancement, teaching health behavior change skills, and facilitating access to social support services.
Medicare does not allow the billing of other services provided on the same day as an obesity behavioral therapy visit, but commercial payers vary with regard to how the visit should be coded, how many visits are allowed in a year, and in reimbursement design. Practices are advised to confirm with the patient's payer whether (1) services are covered, (2) documentation requirements, and (3) which codes to bill. 18 Medicare states that intensive behavioral therapy (IBT) for obesity consists of the following 19 
:
Screening for obesity in adults by using measurement of BMI calculated by dividing weight in kilograms by the square of height in meters (expressed in kg/m 2 );
Dietary (nutritional) assessment; and Intensive behavioral counseling and behavioral therapy to promote sustained weight loss through high-intensity interventions on diet and exercise.
The provision of IBT should be consistent with the USPSTF 5 A's Behavior Change Model framework 20 :
Assess: Ask about/assess behavioral health risk(s) and factors affecting choice of behavior change goals/methods.
Advise: Give clear, specific, and personalized behavior change advice, including information about personal health harms and benefits.
Agree: Collaboratively select appropriate treatment goals and methods based on the patient's interest in and willingness to change the behavior.
Assist: Using behavior change techniques (self-help and/or counseling), aid the patient in achieving agreed-on goals by acquiring the skills, confidence, and social/environmental supports for behavior change, supplemented with adjunctive medical treatments when appropriate.
Arrange: Schedule follow-up contacts (in person or by telephone) to provide ongoing assistance/ support and to adjust the treatment plan as needed, including referral to more intensive or specialized treatment.
For Medicare beneficiaries with obesity who are counseled by a qualified primary care physician or other primary care practitioner and in a primary care setting, CMS covers:
One face-to-face visit every week for the first month;
One face-to-face visit every other week for months 2-6; and One face-to-face visit every month for months 7-12, if the beneficiary meets the 3-kg weight loss requirement as discussed below.
For Medicare beneficiaries, use HCPCS code G0447 (Face-to-face behavioral counseling for obesity, 15 minutes) when providing IBT services. As a preventive service under the Affordable Care Act, there is a $0 copay.
At the 6-month IBT visit, a reassessment of obesity and a determination of the amount of weight loss must be performed. To be eligible for additional face-to-face visits occurring once a month for an additional 6 months, beneficiaries must have achieved a reduction in weight of at least 3 kg during the course of the first 6 months of intensive therapy. This determination must be documented in the physician office records for applicable beneficiaries consistent with usual practice. For beneficiaries who do not achieve a weight loss of at least 3 kg during the first 6 months of intensive therapy, a reassessment of their readiness to change and BMI is appropriate after an additional 6-month period.
Although this Medicare benefit is limited to primary care practitioners and primary care settings, it does not preclude practitioners from screening beneficiaries for obesity and referring those who screen positive with a BMI !30 kg/m 2 to other practitioners and/or settings for intensive multicomponent counseling; however, coverage remains only in the primary care setting.
Medicare will not pay claims for G0447 if submitted by a gastroenterologist or surgeon, because they are not designated as primary care providers for the purposes of providing this service. Mid-level providers such as nurse practitioners and physician assistants are not enrolled as specialists on the Medicare 855 I enrollment form and can bill for G0447 services. Nurse practitioners and physician assistants who provide this service should bill under their name, not incident to the specialist physician.
Counseling that occurs during a preventive medicine encounter is not separately reportable and is considered included as part of the preventive medicine services. However, when preventive counseling is the focus of the visit, it can be separately reported with the appropriate preventive medicine counseling code (99401-99412). For non-Medicare plans, similar individual preventive medicine services to reduce risk factors, including counseling on diet and exercise, could be reported by a physician or other qualified health care professional or dietitian by using the codes in Table 9 .
The documentation in the health care record of obesity screening and counseling should show sufficient patient history to adequately demonstrate that:
The individual has a BMI equal to or greater than 30 kg/m 2 Services were furnished by a qualified health care provider.
It would not be appropriate for non-licensed wellness or life coaches to bill for the above services by using CPT or HCPCS codes, unless there is specific instruction from the payer to do so. 21 
Telemedicine
Telemedicine is the delivery of health care services by using interactive audio, video, or other electronic media for the purpose of diagnosis, consultation, and/or treatment. Although the definition may vary by payer, telemedicine does not generally include the use of audioonly telephone, facsimile machine, FaceTime, Skype, or non-secure email or electronic communication. Telehealth is a broader term that includes telemedicine and may also include ancillary preventive, educational, and non-clinical or curative services that operate in a Health Insurance Portability and Accountability Act (HIPAA) compliant environment.
Telemedicine/telehealth is used to support health care when the provider and patient are physically separated. Typically, the patient communicates with the provider via interactive means that is sufficient to establish the necessary link to the provider who is working at a different location from the patient.
The origination site is the place where the patient is located at the time of the telemedicine/telehealth service.
The provider site is the place where the provider is located at the time the service is provided.
Emerging models of health care recognize that not all care needs to occur in a face-to-face manner. Health plans may elect to provide coverage for real-time (synchronized) telehealth services when such services are equivalent to similar in-person (face-to-face) services for diagnosis, consultation, or treatment. Primary care patients treated with either telemedicine or in-person support were twice as likely (38% and 41%, respectively) to lose 5% or more of their baseline body weight at 2 years compared with a control group of self-directed dieters (19%), with P < .001 for both treatment groups compared with the control. 22 Certain services for management of obesity, such as nutritional, psychological, and medication management, may lend themselves to provision by using telehealth, such as instances when there is an absence of health care professionals who can provide the service to meet the patient's clinical or temporal needs. 23 Telehealth for ongoing therapy around obesity is complicated by inaccurate self-reporting of important decision-making data points, such as weight, calorie intake, and measures of activity. 24 Newer technologies such as wearable activity monitors, self-connecting WiFi scales, and remote photographic analysis of meals can assist the provider in assessing the patient's progress. 25 In addition, frequent real-time text-based feedback and encouragement may be more effective than potentially anxiety producing, infrequent in-person interactions with the care team. 26, 27 For the gastroenterologist who might not have nutritional-behavioral components in their practices, such capable systems may provide an essential adjunct for a successful weight control program. Third-party Web-based platforms that allow for video consultation with physicians and qualified health care professionals are available. Emerging smartphone-based applications offer interactive features that engage the patient and allow for practice customization and connectivity to a variety of established weight tracking systems. Several companies offer HIPAA compliant telemedicine platforms that integrate with wireless scales for automatic updating of patient weight between visits. 28 Patients can schedule their virtual "visits" with the dietitian and "meet" by using a low bandwidth requiring high-resolution system with 256-bit or higher Advanced Encryption Standard encryption.
For Medicare, claims for professional consultations, office visits, individual psychotherapy, and pharmacologic management provided via a telecommunications system are submitted to the carrier that processes claims for the performing physician/practitioner's service area. Physicians/practitioners submit the appropriate CPT procedure code for covered professional telehealth services along with the "GT" modifier ("via interactive audio and video telecommunications system"). By coding and billing the "GT" modifier with a covered telehealth procedure code, the distant site physician/practitioner certifies that the beneficiary was present at an eligible originating site when the telehealth service was furnished.
To claim the facility payment, physicians/practitioners can bill HCPCS code Q3014, telehealth originating site facility fee. For carrier processed claims, the "office" place of service (code 11) is the only payable setting for code Q3014. 29 
Disease Management and Education Services
Disease management is the concept of reducing health care costs and improving quality of life for individuals with chronic conditions by preventing or minimizing the effects of the disease through integrated care. As a system of coordinated health care interventions and communications for defined patient populations with conditions where self-care efforts can be implemented, disease management empowers individuals, working with other health care providers, to manage their disease and prevent complications.
Disease management is a proactive, multidisciplinary, systematic approach to health care delivery that does the following:
Supports the patient-health care professional relationship and plan of care
Optimizes patient care through prevention and proactive interventions based on evidence-based guidelines Incorporates patient self-management
Continuously evaluates health status Measures outcomes
Strives to improve overall health and quality of life in a cost-efficient manner.
During the past decade, chronic care management has become a standard component of health coverage offered by health plans. Chronic care management programs address patient needs along a continuum of care, with wellness/lifestyle management programs offered to those with chronic disease as well as healthy members, disease management to those with chronic conditions, and case management to the critically ill or those with advanced conditions. 30 CPT and HCPCS codes in Table 10 describe disease management services. Modifications may need to be provided that are based on individual need and degree of progress of the patient toward goals.
Pharmacotherapy
Medications approved by the US Food and Drug Administration (FDA) for chronic weight management can be useful adjunctive treatments for patients who have been unsuccessful with cornerstone lifestyle diet and exercise therapy alone. 31 Many medications commonly prescribed for diabetes, depression, and other chronic diseases have weight-altering effects, resulting in weight gain or loss. Knowledgeable prescribing of medications with weight-reducing effects can aid in the prevention and management of obesity and thus improve health. 8 Incorporation of pharmacists into the multidisciplinary management program may assist with the pharmacologic management of obesity.
Alterations in body weight and corresponding metabolic changes can significantly impact the pharmacokinetic and pharmacodynamics properties of medications used by a patient. The potential for significant changes in the absorption, distribution, metabolism, and excretion of medications may warrant a comprehensive pharmacotherapy assessment. This assessment encompasses an evaluation of the intended use, effectiveness, safety, and ability to be taken as intended to achieve drug therapy treatment goals. Modifications in a patient's drug therapy regimen subsequent to weight changes may require collaborative interventions to resolve drug therapy problems such as discontinuing medications, increasing or decreasing doses, and modifying the patient's daily medication schedule consistent with their chronobiology.
Medication therapy management (MTM) is a distinct service or group of services that optimize therapeutic outcomes for individual patients. MTM services are independent of, but can occur in conjunction with, the provision of a medication product. MTM encompasses a broad range of professional activities and responsibilities within the licensed pharmacist's or other qualified health care provider's scope of practice. According to the individual needs of the patient, these services include but are not limited to the following:
Performing or obtaining necessary assessments of the patient's health status;
Formulating a medication treatment plan;
Administration of medication therapy;
Selecting, initiating, modifying, or discontinuing medication therapy;
Monitoring and evaluating the patient's response to therapy, including safety and effectiveness;
Performing a comprehensive medication review to identify, resolve, and prevent medication-related problems, including adverse drug events;
Documenting the care delivered and communicating essential information to the patient's other primary care providers;
Providing verbal education and training designed to enhance patient understanding and appropriate use of his/her medications;
Providing information, support services, and resources designed to enhance patient adherence with his/her therapeutic regimens; and
Coordinating and integrating medication therapy management services within the broader health care management services being provided to the patient.
Practices wishing to incorporate MTM services into a comprehensive management program for obesity may consider CPT codes 99605-99607 for reporting MTM services when provided by a pharmacist (Table 11 ). Physicians or mid-level practitioners who provide MTM services should bill for such by using E/M codes.
Endoscopic Bariatric Therapy
Coding Endoscopic Placement and Removal of Gastric Devices for the Management of Obesity
Available clinical data and manufacturer recommendations indicate 6 months to be the current standard duration of therapy for the intragastric balloon (IGB) devices approved by the FDA as of January 1, 2017.
The ORBERA Intragastric Balloon System (Apollo Endosurgery, Inc, San Diego, CA) is indicated for use as an adjunct to weight reduction for adults with obesity with a BMI !30 and 40 kg/m 2 and is to be used in conjunction with a long-term supervised diet and behavior modification program designed to increase the possibility of significant long-term weight loss and maintenance of that weight loss. ORBERA is indicated for adult patients who have failed more conservative weight reduction alternatives, such as supervised diet, exercise, and behavior modification programs. 32 The ReShape Integrated Dual Balloon System (ReShape Medical Inc, San Clemente, CA) is indicated for weight reduction when used in conjunction with diet and exercise in patients with a BMI of 30-40 kg/m 2 and 1 or more obesity-related comorbid conditions. It is indicated for use in adult patients who have failed weight reduction with diet and exercise alone. 33 The Obalon Balloon System (Obalon Therapeutics Inc, Carlsbad, CA) is a swallowable IGB system indicated for temporary use to facilitate weight loss in adults with obesity (BMI of 30-40 kg/m 2 ) who have failed to lose weight through diet and exercise. The System is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. 34 At present, there are no CPT or HCPCS codes for the endoscopic placement of intragastric space-occupying or gastric pacing devices for the management of obesity. Endoscopic placement should be reported by using code 43999 (Unlisted procedure, stomach). Nonendoscopic placement of an intragastric spaceoccupying device should be reported by using code 99199 (Unlisted special service, procedure or report). Endoscopic removal of a foreign body from the stomach should be reported by using code 43247 (Esophagogastroduodenoscopy, flexible, transoral; with removal of foreign body(s)).
The AspireAssist (Aspire Bariatrics, King of Prussia, PA) is intended to assist in weight reduction of patients with obesity. It is indicated for use in adults aged 22 or older with a BMI of 35.0-55.0 kg/m 2 who have failed to achieve and maintain weight loss with nonsurgical weight loss therapy. The AspireAssist is intended for long-term duration of use in conjunction with lifestyle therapy and continuous medical monitoring. 35 Endoscopic placement of a percutaneous gastrostomy-type device for the management of obesity The manufacturers of the endoscopic devices require the endoscopist to participate in an endoscopic skills training program before the company will sell the device to the physician. The physician must demonstrate advanced upper endoscopy skill and experience evidenced by possession of interventional endoscopy privileges granted locally by the participating hospital or ambulatory facility. The physician is required to use the device as a component of a multidisciplinary weight management practice that provides appropriate endoscopy facilities, nutrition and exercise counseling, and psychological and radiologic long-term support and follow-up.
There are no requirements specifying that placement and/or removal of endoscopic devices for obesity always require general anesthesia and/or intubation. 36 Orotracheal intubation is recommended in patients with BMI >40 kg/m 2 , with obstructive sleep apnea, or with chronic obstructive pulmonary disease. Some endoscopists may elect to perform the initial placement of the device by using general anesthesia and airway intubation. Endoscopic removal of IGB devices must be completed in the presence of an empty stomach, and patients should be nil per os for a minimum of 12 hours before removal. A strict gastric emptying protocol is recommended 48 hours before the patient is due to undergo the balloon removal procedure. Some experienced endoscopists recommend that the airway be protected from aspiration of acid or gastric contents dripping from the IGB for the first several balloon removals, especially if the endoscopist does not frequently remove large foreign bodies from the stomach. If food is found in the stomach on endoscopic examination, then measures (aspiration of stomach contents, endotracheal intubation, or delay of procedure) must be taken to protect the airway. 37 Risks, potential complications, and side effects of intragastric devices should be discussed with the patient before proceeding with placement.
38,39
Constructing an Episode Payment Specific to the Device Portion
When constructing a proposed payment for the device portion of the obesity episode, we recommend consideration of the following by using a model similar to a case rate for a solid organ transplant:
Device cost Placement (endoscopist, anesthesia professional, facility)
Removal (endoscopist, anesthesia professional, facility)
Insurance premium specific to bariatric procedure Pharmaceuticals specific to expected complications after placement of device (eg, dyspepsia, nausea, pain).
Because several studies have reported on the high incidence of patient-reported pain and nausea within 3-7 days after placement of bariatric devices, 40 we encourage the practice to develop a specialty medical home model for management of these patients. 41 Specifically, the patient should have 24/7 access to care management services through a physician or mid-level provider with access to the health record to address urgent intervention-related issues. There needs to be continuity of care with a designated member of the care team and the ability for the patient to obtain successive routine appointments with this individual. 42 The possibility that device insertion and removal may require intubation and general anesthesia should be factored by the physician into the development of the prospective bundle.
Patients with successful outcomes resulting from an obesity intervention may be reluctant to have their therapy discontinued. In addition, patients can be highly mobile because of socioeconomic factors. Some patients will travel long distances to acquire a lower price for a self-funded obesity intervention. Studies have shown that 15%-30% or more of patients who undergo initial placement of a bariatric device are lost to follow-up or do not return. 43 For this reason, we encourage the gastroenterology practice to consider use of the "150%" model when constructing the prospective payment component for endoscopic placement of the device. In this model, the patient is charged one fee up front for the placement and removal of the device, with the amount set at 150% of the costs as described above, with a refund of the additional 50% to the patient only after device is removed. This creates a financial incentive for the patient to remain compliant with follow-up after procedure and to return for removal of the device. Banks and credit card companies with experience in financing plastic surgery, dermatology, and bariatric procedures may be resources for the practice that wishes to offer payment options for patients.
Learning From the Bariatric Ecosystem
To date, more than 700 bariatric surgical programs in the United States are accredited by the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program. 44 Bariatric programs, especially those that are hospital-based, have resources, policies, and procedures regarding the provision of services that can support the gastroenterologist's management of patients with obesity. Nonsurgical management of patients with obesity should be viewed as a continuum of evidencebased care designed to not only improve identification of patients with obesity but also offer patients individualized, multidisciplinary management options for their health issues. Gastroenterology practices who are considering establishment of an obesity program that incorporates endoscopic placement of devices for the management of obesity are encouraged to meet with the administration of their local hospital that offers bariatric programs to identify opportunities for collaboration, because the hospital system may be the principal employer of primary care professionals.
The hospital often has greater influence when negotiating with insurance companies for coverage of emerging technologies and device costs. Hospital reimbursement for services rendered is not necessarily directly related to the costs incurred; a major variable is the direct cost of devices implanted. Securing reimbursement for endoscopic obesity devices may be challenging, especially when the technology is new to the market. 45 Development of a third-party commercial payer contract that includes the costs of emerging technologies takes substantial time and effort, and there is a risk that Medicare contractors and Medicaid may issue non-coverage for these devices. Typical Medicare outpatient hospital reimbursement is by case rate mechanisms, whereas commercial payer contracts can be fixed per diems, case rates, or some combination that may or may not include a carve-out for the device. Capitation contracts may require revisions to accommodate the introduction of new technology. Working with the hospital to maximize purchasing leverage and securing appropriate reimbursement will help manage true costs and coverage. 46 Critically assessing opportunities for collaboration and standardizing and streamlining patient throughput and care processes are essential components to the success of a bariatric program in the gastroenterology practice.
Another lesson to be learned from the bariatric ecosystem is risk. Physicians who elect to do endoscopic therapy for the management of bariatric and/or metabolic diseases should notify their medical liability carrier before starting to do so. In addition, it is important to determine upfront what happens to the patient if there is a complication of a bariatric procedure. Insurance policies may include language to the effect of "complications of a non-covered service are not covered by the plan." 47, 48 If the patient suffers a complication of the bariatric endoscopic procedure, the subsequent costs such as emergency department, hospital, anesthesia, physician/health care professionals, laboratory, imaging, and other services may be contractually excluded from coverage and reimbursement. In such circumstances the endoscopist may be at risk for litigation over the costs of complications. For that reason, the authors encourage the gastroenterology practice to investigate insurance products that protect the patient against complicationrelated medical expenses if a complication should occur. 49 
Conclusion
Obesity is a chronic disease with complex pathophysiological and behavioral components that require a long-term multidisciplinary approach to therapy. The cornerstone of treatment is the adoption of a reduced calorie diet and increased physical activity program, along with education and behavioral support. Because obesity has reached epidemic proportions, innovative coordinated approaches to care are needed. Pharmaceutical treatments and endoscopic bariatric therapies are likely to play an increasingly important role in achieving sustainable improvement in health outcomes.
As digestive disease and endoscopy specialists, gastroenterologists are poised to play a key role in treating obesity. Developing familiarity with preventive services and payment models within an episode-of-care framework for obesity presents an opportunity for gastroenterologists to expand their practices and ensure they are seen by payers, purchasers, and consumers as delivering high-value, high-quality care in the treatment of obesity. CPT codes does not constitute coding advice or recommendations by the American Gastroenterological Association. Inclusion or exclusion of a procedure or service does not imply any health insurance coverage or reimbursement policy. This episode framework is not intended to impose requirements on practices or to establish a local, regional, or national legal standard of care. There are various appropriate treatment modalities for each patient, and the physician must use her or his judgment in selecting from among feasible treatment options. The ultimate judgment regarding appropriateness of any specific procedure or course of action must be made by the physician along with the patient, in light of all the circumstances presented. All that should be expected is that the physician will follow a reasonable course of action based on current knowledge, available resources, and the needs of the patient in order to deliver effective and safe medical care. CPT codes, descriptions, and other data only are copyright 2016 American Medical Association (AMA). All rights reserved. CPT is a registered trademark of the American Medical Association.
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